Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 121

1.

The Kettlebell Lunge Clean exercise.

Henkin J, Bento J, Liebenson C.

J Bodyw Mov Ther. 2018 Oct;22(4):980-982. doi: 10.1016/j.jbmt.2018.09.079. Epub 2018 Sep 21.

PMID:
30368345
2.

The Search for Anticancer Agents from Tropical Plants.

Henkin JM, Ren Y, Soejarto DD, Kinghorn AD.

Prog Chem Org Nat Prod. 2018;107:1-94. doi: 10.1007/978-3-319-93506-5_1.

PMID:
30178270
3.

Extended Intravitreal Rabbit Eye Residence of Nanoparticles Conjugated With Cationic Arginine Peptides for Intraocular Drug Delivery: In Vivo Imaging.

Melgar-Asensio I, Kandela I, Aird F, Darjatmoko SR, de Los Rios C, Sorenson CM, Albert DM, Sheibani N, Henkin J.

Invest Ophthalmol Vis Sci. 2018 Aug 1;59(10):4071-4081. doi: 10.1167/iovs.18-24087.

4.

Reverting the molecular fingerprint of tumor dormancy as a therapeutic strategy for glioblastoma.

Tiram G, Ferber S, Ofek P, Eldar-Boock A, Ben-Shushan D, Yeini E, Krivitsky A, Blatt R, Almog N, Henkin J, Amsalem O, Yavin E, Cohen G, Lazarovici P, Lee JS, Ruppin E, Milyavsky M, Grossman R, Ram Z, Calderón M, Haag R, Satchi-Fainaro R.

FASEB J. 2018 Jun 1:fj201701568R. doi: 10.1096/fj.201701568R. [Epub ahead of print]

PMID:
29856660
5.

Revisiting the linkage between ethnomedical use and development of new medicines: A novel plant collection strategy towards the discovery of anticancer agents.

Henkin JM, Sydara K, Xayvue M, Souliya O, Kinghorn AD, Burdette JE, Chen WL, Elkington BG, Soejarto DD.

J Med Plant Res. 2017 Oct;11(40):621-634. Epub 2017 Oct 25.

6.

Pre-metastatic cancer exosomes induce immune surveillance by patrolling monocytes at the metastatic niche.

Plebanek MP, Angeloni NL, Vinokour E, Li J, Henkin A, Martinez-Marin D, Filleur S, Bhowmick R, Henkin J, Miller SD, Ifergan I, Lee Y, Osman I, Thaxton CS, Volpert OV.

Nat Commun. 2017 Nov 6;8(1):1319. doi: 10.1038/s41467-017-01433-3.

7.

Sustaining Intravitreal Residence With L-Arginine Peptide-Conjugated Nanocarriers.

Li H, Liu W, Sorenson CM, Sheibani N, Albert DM, Senanayake T, Vinogradov S, Henkin J, Zhang HF.

Invest Ophthalmol Vis Sci. 2017 Oct 1;58(12):5142-5150. doi: 10.1167/iovs.17-22160.

8.

Co-targeting the tumor endothelium and P-selectin-expressing glioblastoma cells leads to a remarkable therapeutic outcome.

Ferber S, Tiram G, Sousa-Herves A, Eldar-Boock A, Krivitsky A, Scomparin A, Yeini E, Ofek P, Ben-Shushan D, Vossen LI, Licha K, Grossman R, Ram Z, Henkin J, Ruppin E, Auslander N, Haag R, Calderón M, Satchi-Fainaro R.

Elife. 2017 Oct 4;6. pii: e25281. doi: 10.7554/eLife.25281.

9.

Novel characteristics identified in two cases of feline cowpox virus infection.

Breheny CR, Fox V, Tamborini A, O'Halloran C, Robertson E, Cazzini P, Birn-Jeffery D, Henkin J, Schwartz T, Scase T, Powell R, Gunn-Moore D.

JFMS Open Rep. 2017 Jul 11;3(2):2055116917717191. doi: 10.1177/2055116917717191. eCollection 2017 Jul-Dec.

10.
11.

Tooth retention through endodontic microsurgery or tooth replacement using single implants: a systematic review of treatment outcomes.

Torabinejad M, Landaez M, Milan M, Sun CX, Henkin J, Al-Ardah A, Kattadiyil M, Bahjri K, Dehom S, Cortez E, White SN.

J Endod. 2015 Jan;41(1):1-10. doi: 10.1016/j.joen.2014.09.002. Epub 2014 Oct 11. Review.

PMID:
25306305
12.

Micro-computed tomography assessment of human alveolar bone: bone density and three-dimensional micro-architecture.

Kim YJ, Henkin J.

Clin Implant Dent Relat Res. 2015 Apr;17(2):307-13. doi: 10.1111/cid.12109. Epub 2013 Jul 9.

PMID:
23837565
13.

Beginning of viniculture in France.

McGovern PE, Luley BP, Rovira N, Mirzoian A, Callahan MP, Smith KE, Hall GR, Davidson T, Henkin JM.

Proc Natl Acad Sci U S A. 2013 Jun 18;110(25):10147-52. doi: 10.1073/pnas.1216126110. Epub 2013 Jun 3. Erratum in: Proc Natl Acad Sci U S A. 2013 Jul 23;110(30):12498.

14.

Prospective study of thrombospondin-1 mimetic peptides, ABT-510 and ABT-898, in dogs with soft tissue sarcoma.

Sahora AI, Rusk AW, Henkin J, McKeegan EM, Shi Y, Khanna C.

J Vet Intern Med. 2012 Sep-Oct;26(5):1169-76. doi: 10.1111/j.1939-1676.2012.00966.x. Epub 2012 Jul 21.

15.

Changes in mRNA expression of adenosine receptors in human chronic periodontitis.

Sun CX, Wall NR, Angelov N, Ririe C, Chen JW, Boskovic DS, Henkin JM.

Chin J Dent Res. 2011;14(2):113-20.

16.

Therapies using anti-angiogenic peptide mimetics of thrombospondin-1.

Henkin J, Volpert OV.

Expert Opin Ther Targets. 2011 Dec;15(12):1369-86. doi: 10.1517/14728222.2011.640319. Epub 2011 Dec 5. Review.

PMID:
22136063
17.

ABT-898 induces tumor regression and prolongs survival in a mouse model of epithelial ovarian cancer.

Campbell N, Greenaway J, Henkin J, Petrik J.

Mol Cancer Ther. 2011 Oct;10(10):1876-85. doi: 10.1158/1535-7163.MCT-11-0402. Epub 2011 Aug 15.

18.

Implant failure associated with actinomycosis in a medically compromised patient.

Sun CX, Henkin JM, Ririe C, Javadi E.

J Oral Implantol. 2013 Apr;39(2):206-9. doi: 10.1563/AAID-JOI-D-11-00028. Epub 2011 Jul 18.

PMID:
21767210
19.

Recombinant human bone morphogenetic protein 2 combined with an osteoconductive bulking agent for mandibular continuity defects in nonhuman primates.

Herford AS, Lu M, Buxton AN, Kim J, Henkin J, Boyne PJ, Caruso JM, Rungcharassaeng K, Hong J.

J Oral Maxillofac Surg. 2012 Mar;70(3):703-16. doi: 10.1016/j.joms.2011.02.088. Epub 2011 May 6.

PMID:
21549480
20.

Hyperplastic dental follicle - review of literature and report of two cases in one family.

Sun CX, Ririe C, Henkin JM.

Chin J Dent Res. 2010;13(1):71-5. Review.

21.

A thrombospondin-mimetic peptide, ABT-898, suppresses angiogenesis and promotes follicular atresia in pre- and early-antral follicles in vivo.

Garside SA, Henkin J, Morris KD, Norvell SM, Thomas FH, Fraser HM.

Endocrinology. 2010 Dec;151(12):5905-15. doi: 10.1210/en.2010-0283. Epub 2010 Sep 29.

PMID:
20881256
22.
23.

Plasminogen kringle 5 induces apoptosis of brain microvessel endothelial cells: sensitization by radiation and requirement for GRP78 and LRP1.

McFarland BC, Stewart J Jr, Hamza A, Nordal R, Davidson DJ, Henkin J, Gladson CL.

Cancer Res. 2009 Jul 1;69(13):5537-45. doi: 10.1158/0008-5472.CAN-08-4841. Epub 2009 Jun 23.

24.

ABT-510 induces tumor cell apoptosis and inhibits ovarian tumor growth in an orthotopic, syngeneic model of epithelial ovarian cancer.

Greenaway J, Henkin J, Lawler J, Moorehead R, Petrik J.

Mol Cancer Ther. 2009 Jan;8(1):64-74. doi: 10.1158/1535-7163.MCT-08-0864.

25.

ABT-510, a modified type 1 repeat peptide of thrombospondin, inhibits malignant glioma growth in vivo by inhibiting angiogenesis.

Anderson JC, Grammer JR, Wang W, Nabors LB, Henkin J, Stewart JE Jr, Gladson CL.

Cancer Biol Ther. 2007 Mar;6(3):454-62. Epub 2007 Mar 26.

PMID:
17384534
26.

Thrombospondin-1 peptide ABT-510 combined with valproic acid is an effective antiangiogenesis strategy in neuroblastoma.

Yang Q, Tian Y, Liu S, Zeine R, Chlenski A, Salwen HR, Henkin J, Cohn SL.

Cancer Res. 2007 Feb 15;67(4):1716-24.

27.

Cooperative activity of cytotoxic chemotherapy with antiangiogenic thrombospondin-I peptides, ABT-526 in pet dogs with relapsed lymphoma.

Rusk A, Cozzi E, Stebbins M, Vail D, Graham J, Valli V, Henkin J, Sharpee R, Khanna C.

Clin Cancer Res. 2006 Dec 15;12(24):7456-64.

28.

Preclinical evaluation of antiangiogenic thrombospondin-1 peptide mimetics, ABT-526 and ABT-510, in companion dogs with naturally occurring cancers.

Rusk A, McKeegan E, Haviv F, Majest S, Henkin J, Khanna C.

Clin Cancer Res. 2006 Dec 15;12(24):7444-55.

29.

Discovery and optimization of anthranilic acid sulfonamides as inhibitors of methionine aminopeptidase-2: a structural basis for the reduction of albumin binding.

Sheppard GS, Wang J, Kawai M, Fidanze SD, BaMaung NY, Erickson SA, Barnes DM, Tedrow JS, Kolaczkowski L, Vasudevan A, Park DC, Wang GT, Sanders WJ, Mantei RA, Palazzo F, Tucker-Garcia L, Lou P, Zhang Q, Park CH, Kim KH, Petros A, Olejniczak E, Nettesheim D, Hajduk P, Henkin J, Lesniewski R, Davidsen SK, Bell RL.

J Med Chem. 2006 Jun 29;49(13):3832-49.

PMID:
16789740
30.

Development of sulfonamide compounds as potent methionine aminopeptidase type II inhibitors with antiproliferative properties.

Kawai M, BaMaung NY, Fidanze SD, Erickson SA, Tedrow JS, Sanders WJ, Vasudevan A, Park C, Hutchins C, Comess KM, Kalvin D, Wang J, Zhang Q, Lou P, Tucker-Garcia L, Bouska J, Bell RL, Lesniewski R, Henkin J, Sheppard GS.

Bioorg Med Chem Lett. 2006 Jul 1;16(13):3574-7. Epub 2006 May 2.

PMID:
16632353
31.

Metronomic low-dose chemotherapy boosts CD95-dependent antiangiogenic effect of the thrombospondin peptide ABT-510: a complementation antiangiogenic strategy.

Yap R, Veliceasa D, Emmenegger U, Kerbel RS, McKay LM, Henkin J, Volpert OV.

Clin Cancer Res. 2005 Sep 15;11(18):6678-85.

32.

Concentrations of glycolytic enzymes and other cytosolic proteins in the diffusible fraction of a vertebrate muscle proteome.

Maughan DW, Henkin JA, Vigoreaux JO.

Mol Cell Proteomics. 2005 Oct;4(10):1541-9. Epub 2005 Jun 27.

33.

Kringle 5 of human plasminogen induces apoptosis of endothelial and tumor cells through surface-expressed glucose-regulated protein 78.

Davidson DJ, Haskell C, Majest S, Kherzai A, Egan DA, Walter KA, Schneider A, Gubbins EF, Solomon L, Chen Z, Lesniewski R, Henkin J.

Cancer Res. 2005 Jun 1;65(11):4663-72.

34.

Thrombospondin-1 mimetic peptide inhibitors of angiogenesis and tumor growth: design, synthesis, and optimization of pharmacokinetics and biological activities.

Haviv F, Bradley MF, Kalvin DM, Schneider AJ, Davidson DJ, Majest SM, McKay LM, Haskell CJ, Bell RL, Nguyen B, Marsh KC, Surber BW, Uchic JT, Ferrero J, Wang YC, Leal J, Record RD, Hodde J, Badylak SF, Lesniewski RR, Henkin J.

J Med Chem. 2005 Apr 21;48(8):2838-46.

PMID:
15828822
35.

Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; Implications for cellular surrogate marker analysis of antiangiogenesis.

Shaked Y, Bertolini F, Man S, Rogers MS, Cervi D, Foutz T, Rawn K, Voskas D, Dumont DJ, Ben-David Y, Lawler J, Henkin J, Huber J, Hicklin DJ, D'Amato RJ, Kerbel RS.

Cancer Cell. 2005 Jan;7(1):101-11.

36.

Mass processing--an improved technique for protein identification with mass spectrometry data.

Henkin JA, Jennings ME, Matthews DE, Vigoreaux JO.

J Biomol Tech. 2004 Dec;15(4):230-7.

37.

Peroxisome proliferator-activated receptor gamma ligands improve the antitumor efficacy of thrombospondin peptide ABT510.

Huang H, Campbell SC, Bedford DF, Nelius T, Veliceasa D, Shroff EH, Henkin J, Schneider A, Bouck N, Volpert OV.

Mol Cancer Res. 2004 Oct;2(10):541-50.

38.

Lysyl 4-aminobenzoic acid derivatives as potent small molecule mimetics of plasminogen kringle 5.

Sheppard GS, Kawai M, Craig RA, Davidson DJ, Majest SM, Bell RL, Henkin J.

Bioorg Med Chem Lett. 2004 Feb 23;14(4):965-6.

PMID:
15013002
39.

3-Amino-2-hydroxyamides and related compounds as inhibitors of methionine aminopeptidase-2.

Sheppard GS, Wang J, Kawai M, BaMaung NY, Craig RA, Erickson SA, Lynch L, Patel J, Yang F, Searle XB, Lou P, Park C, Kim KH, Henkin J, Lesniewski R.

Bioorg Med Chem Lett. 2004 Feb 23;14(4):865-8.

PMID:
15012983
40.

Tumor suppression by a rationally designed reversible inhibitor of methionine aminopeptidase-2.

Wang J, Sheppard GS, Lou P, Kawai M, BaMaung N, Erickson SA, Tucker-Garcia L, Park C, Bouska J, Wang YC, Frost D, Tapang P, Albert DH, Morgan SJ, Morowitz M, Shusterman S, Maris JM, Lesniewski R, Henkin J.

Cancer Res. 2003 Nov 15;63(22):7861-9.

41.
42.

Mutations that affect flightin expression in Drosophila alter the viscoelastic properties of flight muscle fibers.

Henkin JA, Maughan DW, Vigoreaux JO.

Am J Physiol Cell Physiol. 2004 Jan;286(1):C65-72. Epub 2003 Sep 3.

43.

Contrasting effects of VEGF gene disruption in embryonic stem cell-derived versus oncogene-induced tumors.

Viloria-Petit A, Miquerol L, Yu JL, Gertsenstein M, Sheehan C, May L, Henkin J, Lobe C, Nagy A, Kerbel RS, Rak J.

EMBO J. 2003 Aug 15;22(16):4091-102.

44.

Physiologically relevant metal cofactor for methionine aminopeptidase-2 is manganese.

Wang J, Sheppard GS, Lou P, Kawai M, Park C, Egan DA, Schneider A, Bouska J, Lesniewski R, Henkin J.

Biochemistry. 2003 May 6;42(17):5035-42.

PMID:
12718546
45.

Paclitaxel at ultra low concentrations inhibits angiogenesis without affecting cellular microtubule assembly.

Wang J, Lou P, Lesniewski R, Henkin J.

Anticancer Drugs. 2003 Jan;14(1):13-9.

PMID:
12544254
46.

Low density lipoprotein (LDL) receptor-related protein 1B impairs urokinase receptor regeneration on the cell surface and inhibits cell migration.

Li Y, Knisely JM, Lu W, McCormick LM, Wang J, Henkin J, Schwartz AL, Bu G.

J Biol Chem. 2002 Nov 1;277(44):42366-71. Epub 2002 Aug 22.

47.

Inhibition of tumor growth by systemic treatment with thrombospondin-1 peptide mimetics.

Reiher FK, Volpert OV, Jimenez B, Crawford SE, Dinney CP, Henkin J, Haviv F, Bouck NP, Campbell SC.

Int J Cancer. 2002 Apr 10;98(5):682-9.

48.

Changes in selected fitness parameters following six weeks of snowshoe training.

Connolly DA, Henkin JA, Tyzbir RS.

J Sports Med Phys Fitness. 2002 Mar;42(1):14-8.

PMID:
11832869
49.

Structure-directed discovery of potent non-peptidic inhibitors of human urokinase that access a novel binding subsite.

Nienaber VL, Davidson D, Edalji R, Giranda VL, Klinghofer V, Henkin J, Magdalinos P, Mantei R, Merrick S, Severin JM, Smith RA, Stewart K, Walter K, Wang J, Wendt M, Weitzberg M, Zhao X, Rockway T.

Structure. 2000 May 15;8(5):553-63.

Supplemental Content

Loading ...
Support Center